A 68-year-old woman presents to the outpatient clinic for evaluation of a right foot ulcer… — USMLE Step 2 CK

A $68$ -year-old woman presents to the outpatient clinic for evaluation of a right foot ulcer. She has a $15$ -year history of type $2$ diabetes mellitus, which is complicated by severe peripheral neuropathy and chronic kidney disease. The patient first noticed the ulcer $3$ weeks ago. She reports no fevers, chills, or foot pain. Vital signs show a temperature of $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), blood pressure of $132/78$ mm Hg, and heart rate of $76$ /min. Physical examination reveals a $2 \times 2$ cm ulcer on the plantar surface of the first metatarsal head. There is no surrounding erythema, warmth, fluctuance, or purulent drainage. A sterile metal probe is inserted into the ulcer and palpates hard, gritty tissue at the base. Laboratory studies reveal a leukocyte count of $8,200/\text{mm}^3$ and an erythrocyte sedimentation rate of $88$ mm/h. Plain radiography of the right foot demonstrates periosteal elevation and cortical erosion of the first metatarsal head. Which of the following is the most appropriate next step in the management of this patient?

A
Initiate empiric intravenous vancomycin and piperacillin-tazobactam
B
Obtain a superficial swab culture of the ulcer base and start oral cephalexin
Perform a percutaneous bone biopsy for microbiological cultureAnswer
D
Begin a $6$ -week course of empiric oral ciprofloxacin and clindamycin
E
Obtain magnetic resonance imaging of the right foot and initiate empiric broad-spectrum antibiotics

Answer

The most appropriate next step is to perform a percutaneous bone biopsy for microbiological culture to allow for targeted antibiotic therapy.

The patient has diabetic foot osteomyelitis, which is diagnosed clinically by a positive probe-to-bone test and confirmed by characteristic findings on plain radiography (periosteal elevation, cortical erosion). Because she is hemodynamically stable and lacks signs of systemic toxicity or severe local soft-tissue infection (e.g., surrounding cellulitis, abscess), antimicrobial therapy should be withheld until a definitive microbiological tissue diagnosis is obtained. A percutaneous or surgical bone biopsy is the gold standard for identifying the causative pathogens in osteomyelitis. This approach allows for targeted, narrow-spectrum antibiotic therapy and avoids the complications, adverse effects, and resistance patterns associated with prolonged empiric broad-spectrum regimens.

Step-by-Step Solution

Evaluate clinical and radiographic findings to confirm the diagnosis.

The positive probe-to-bone test combined with cortical erosions and periosteal elevation on plain radiography confirms the diagnosis of diabetic foot osteomyelitis.

Establishing a definitive diagnosis is required before determining the necessity and sequence of further interventions.

Assess the patient's clinical stability and the severity of the local soft-tissue infection.

The patient is hemodynamically stable, afebrile, and lacks signs of systemic toxicity or severe local spreading infection (e.g., severe cellulitis, abscess).

Clinical stability dictates whether emergent empiric antibiotics are required or if they can be safely withheld to obtain optimal microbiological data.

Determine the optimal diagnostic sequence for stable diabetic foot osteomyelitis.

Hold antimicrobial therapy and proceed directly to a percutaneous bone biopsy.

A bone biopsy provides the most accurate microbiological data. Withholding antibiotics prior to the biopsy ensures a higher diagnostic yield, facilitating targeted antimicrobial therapy in accordance with stewardship principles.

Key Concept

In clinically stable patients with diabetic foot osteomyelitis lacking systemic toxicity or severe local infection, antibiotic therapy should be withheld until a bone biopsy can be obtained for targeted, culture-directed therapy.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic